Tag: insightec

[Insightec in Parkinsons News Today] Focused Ultrasound in Parkinson’s: A Conversation With Arjun Desai, MD

Last November, the U.S. Food and Drug Administration approved Exablate Neuro to treat motor symptoms in Parkinson’s disease patients, as reported by Parkinson’s News Today‘s Patricia Inacio, PhD. Created by medical device company Insightec, Exablate Neuro is a magnetic resonance, image-guided, focused ultrasound (MRgFUS) system that can treat tremors noninvasively. Read more...

Read More

[Insightec in PR Newswire] Insightec receives FDA IDE approval and “Breakthrough” designation for NSCLC Brain Mets Study and IDE approval for Liquid Biopsy Study

HAIFA, Israel & MIAMI, March 9, 2022 /CNW/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that it has received FDA approval of two pivotal investigational device exemptions (IDE) for its Exablate Neuro system – one for primary non-small cell lung cancer (NSCLC) that has metastasized to the brain in conjunction with standard-of-care Keytruda®, and one for enhanced efficacy of liquid biopsy for recurrence monitoring of patients with primary brain cancer. The FDA has also granted “Breakthrough Device” designation for the NSCLC treatment, helping to expedite its development and review. Read...

Read More

Latest from Twitter